HOT NEWS
Merck KGaA
Merck KGaAMerck is a global pharmaceutical and chemical company with total revenues of € 7.1 billion in 2007, a history that began in 1668, and a future shaped by 32,458 employees in 59 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since. For more information, please visit http://www.merck.de.

Merck KGaA RSS Channel

Filter     Display # 
# Article Title Hits
1 FY2009: Merck KGaA Revenues Rise by 2.1% to € 7.7 Billion 265
2 New Data From CLARITY Study on Disease Activity in MS Patients 1053
3 Merck KGaA Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in Europe 934
4 Q1/2009: Merck Revenues Remain Stable at € 1.9 Billion 537
5 Annual General Meeting of Merck KGaA: Shareholders Approve Dividend of € 1.50 per Share 708
6 Merck KGaA Launches Strategic Venture Capital Fund 733
7 Merck KGaA and Fast Forward, LLC Announce Collaboration 715
8 The safety of patients is of utmost importance to Merck 863
9 Merck: 2008 Operating Result Rises 16% to € 1,131 Million 672
10 Oral Investigational Multiple Sclerosis Treatment to Complete a Two-Year Pivotal Study 627
11 Merck KGaA and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics 609
12 Merck KGaA's Kuvan Receives Marketing Authorization in Europe 576
13 Merck KGaA Acquires Bio-Fyt Pharma in Belgium 655
 
Bookmark and Share

Banner